Anastomosis Device Market is projected to grow from USD 3.0 billion in 2022 to USD 4.4 billion by 2027, at a CAGR of 8.3% from 2022 to 2027 according to a new report by MarketsandMarkets™. The increasing incidence of target diseases and the subsequent growth in the number of surgical procedures, the growing demand for minimally invasive surgeries, and technological advancements are the major factors driving the market’s growth. Emerging economies such as China, Japan, and India are providing profitable opportunities for the players operating in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=5343963

Browse in-depth TOC on “Anastomosis Device Market”
289 – Tables
42 – Figures
305 – Pages

List of Key Players in Anastomosis Device Market are:

  1. Johnson & Johnson (US),
  2. Medtronic Plc (Ireland),
  3. B. Braun Melsungen (Germany),
  4. Intuitive Surgical Inc. (US),
  5. Boston Scientific Corporation (US),
  6. Artivion, Inc. (US),
  7. Smith & Nephew Plc (UK),
  8. Becton, Dickinson and Company (US),
  9. CONMED Corporation (US),
  10. Advanced Medical Solutions Group Plc (UK),
  11. Baxter International, Inc. (US),
  12. Teleflex (US),
  13. Meril Life Sciences (India),
  14. Surgical Specialties Corporation (US),
  15. Péters Surgical (France),
  16. DemeTECH Corporation (US),
  17. Purple Surgical (UK),
  18. Internacional Farmacéutica S.A. de C.V. (Mexico),
  19. BioSintex (Romania),
  20. Lotus Surgicals (India),
  21. Mellon Medical (Netherlands),
  22. Frankenman International (China),
  23. EndoEvolution (US),
  24. Welfare Medical (UK) and
  25. Unisur Lifecare (India).

Anastomosis Device Market Dynamics:

  1. Driver: Growing number of surgical procedures worldwide
  2. Opportunity: Growing healthcare markets in emerging economies
  3. Restraint: High cost of devices and extensive clinical data requirements for launching new products
  4. Challenge: Requirement of skilled personnel for optimal utilization of products

Key Findings of the Study:

  1. Surgical Staplers segment accounted for the largest share of the anastomosis devices market, by product.
  2. Cardiovascular & Thoracic Surgery accounted for the largest share in the market, by application.
  3. Hospitals segment accounted for the largest share in the market, by end users.
  4. North America is the largest regional market for anastomosis devices.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=5343963

“Surgical Staplers segment accounted for the largest share of the anastomosis devices market, by product.”

The anastomosis device market is segmented into surgical staplers, surgical sutures, and surgical sealants & adhesives. In 2021, the surgical staplers segment accounted for the largest share of the market. The surgical staplers market is further segmented into manual and powered surgical staplers. In 2021, the manual surgical staplers segment accounted for the largest share of the surgical staplers market. The large share of this segment can be attributed to the wide range of advantages associated with these devices, such as ease of use, minimal risk of complications like blood loss/leakage, shorter operating time, and reduced hospital costs.

“Cardiovascular & Thoracic Surgery accounted for the largest share in the market, by application.”

The anastomosis device market has been segmented into cardiovascular & thoracic surgery, gastrointestinal surgery, orthopaedic surgery, gynaecological surgery, and other applications. In 2021, the cardiovascular & thoracic surgery segment accounted for the largest share of the temperature monitoring market.  

For More Info @ https://www.globenewswire.com/news-release/2022/09/07/2511537/0/en/Anastomosis-Device-Market-worth-4-4-billion-by-2027-Exclusive-Report-by-MarketsandMarkets.html